Search Result "prodromal psychosis"
Stress and the Prodromal Phase of Psychosis
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 4 Year: 2012 Page: 527-533
Author(s): Carrie W. Holtzman, Daniel I. Shapiro, Hanan D. Trotman, Elaine F. Walker
Philosophical Issues in the Prodromal Phase of Psychosis
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 4 Year: 2012 Page: 596-605
Author(s): Matthew Broome, Paolo Fusar-Poli
Cognitive Behavioral Therapy in Prodromal Psychosis
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 4 Year: 2012 Page: 558-565
Author(s): Jean Addington, Catherine Marshall, Paul French
Cannabis Use in Patients at Clinical High Risk of Psychosis: Impact on Prodromal Symptoms and Transition to Psychosis
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 32 Year: 2012 Page: 5036-5044
Author(s): Floor J. van der Meer,Eva Velthorst,Carin J. Meijer,Marise W.J. Machielsen,Lieuwe de Haan
Anandamide Dysfunction in Prodromal and Established Psychosis
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 32 Year: 2012 Page: 5188-5193
Author(s): F. Markus Leweke
Biochemical Markers of Impending Psychosis
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 4 Year: 2012 Page: 505-509
Author(s): Enzo Emanuele, Valentina Martinelli, Vera Abbiati, Paolo Fusar-Poli, Pierluigi Politi
The Ultra High Risk Approach to Define Psychosis Risk
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 4 Year: 2012 Page: 346-350
Author(s): Alison R. Yung, Paolo Fusar-Poli, Barnaby Nelson
Is Dopamine Neurotransmission Altered in Prodromal Schizophrenia? A Review of the Evidence
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 12 Year: 2012 Page: 1568-1579
Author(s): Martin Bauer, Nicole Praschak-Rieder, Siegfried Kasper, Matthaus Willeit
Early Intervention in Psychosis: Rationale, Results and Implications for Treatment of Adolescents at Risk
Journal: Adolescent Psychiatry
Volume: 2 Issue: 2 Year: 2012 Page: 125-139
Author(s): William R. McFarlane,Barbara Cornblatt,Cameron S. Carter
Glutamate and Psychosis Risk
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 4 Year: 2012 Page: 466-478
Author(s): Alice Egerton, Paolo Fusar-Poli, James M. Stone